Agnes Paillard Is Co-Opted as an Independent Member of Fermentalg''s Board of Directors
(firmenpresse) - LIBOURNE, FRANCE -- (Marketwired) -- 10/28/14 -- Fermentalg (EURONEXT PARIS: ), an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, is pleased to announce that Mrs Agnès Paillard has been co-opted as an independent director(1).
Agnès Paillard is the current Chairman of the Board of Directors of the French National Institute for Industrial Property (), President of the competitiveness cluster and Vice-President responsible for regional innovation policy for . A graduate of ESPCI ParisTech, Agnès Paillard was Chief Executive of Serma Technologies from 1995 to 2002 before being appointed Deputy Director in charge of economic development, research and technology transfer for the Regional Council of Aquitaine until 2009.
For Pierre Calleja, Founder and Chairman and CEO of Fermentalg: "We are immensely proud to welcome an independent director of Agnès Paillard''s caliber and precious expertise. I would also like to take this opportunity to thank Sofiprotéol representative Claire Maingon for her work as a member of the Board of Directors over the past 2 years, and once again pay homage to Professor Daniel Thomas who was a director for Fermentalg from 2011 and who sadly passed away last May. The day of tribute organized by the Enzyme and Cellular Engineering laboratory of the Université de Technologie de Compiègne on 10 October once again brought to light the Professor''s extensive contribution to the field of life sciences and biotechnologies."
Following this co-opting, Fermentalg''s Board of Directors shall include:
Pierre Calleja, Chairman
Bernard Maitre, representative for Emertec Gestion
Agnès Paillard, independent director
Gilles Schang, representative for Bpifrance Investissement
Stéphane Villecroze, representative for Demeter Partners
Fermentalg''s decision to appoint a new independent director to its Board is part of its commitment to implementing the procedures needed to ensure its compliance with the core recommendations of MiddleNext''s corporate governance code.
Founded in 2009 by Pierre Calleja, Fermentalg is an industrial biotechnology company that specializes in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Its patented technology allows it to target a range of fast-growing global markets, from nutrition and animal feed to cosmetics and health, green chemistry and energy. Fermentalg has already signed its 1st industrial and commercial joint-venture for the production of Omega-3 oils rich in EPA and DHA as well as several other partnerships with leading industrial groups. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: .
(1) The resolution to co-opt Mrs Paillard will be ratified by Fermentalg''s next Annual General Meeting of shareholders.
Pierre Calleja
Chairman and CEO
Tel: +33 (0)5 57 25 02 20
Paul Michalet
Chief Finance, Strategy & Business Officer
Tel: +33 (0)5 57 25 79 76
Alexandra Prisa
Tel: +33 (0)1 53 67 35 79
Jerome Fabreguettes-Leib
Tel: +33 (0)1 77 35 04 36
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.10.2014 - 03:51 Uhr
Sprache: Deutsch
News-ID 1313140
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
LIBOURNE, FRANCE
Phone:
Kategorie:
Commodity Chemicals
Anmerkungen:
Diese Pressemitteilung wurde bisher 265 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Agnes Paillard Is Co-Opted as an Independent Member of Fermentalg''s Board of Directors
"
steht unter der journalistisch-redaktionellen Verantwortung von
Fermentalg (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
